Ignite Creation Date:
2025-12-24 @ 10:30 PM
Ignite Modification Date:
2026-01-01 @ 5:26 PM
Study NCT ID:
NCT00505635
Status:
TERMINATED
Last Update Posted:
2020-09-24
First Post:
2007-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Biochemotherapy With Temozolomide for Metastatic Melanoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2010-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-20
First Submit QC Date:
None
Study First Post Date:
2007-07-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-03-26
Results First Submit QC Date:
None
Results First Post Date:
2012-04-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-01
Last Update Post Date:
2020-09-24
Last Update Post Date Type:
ACTUAL